Design Platform for Vaccine & Oncolytic Virus development. Vaccines: COVID, Flu, RSV, Dengue. Oncology: Breast Cancer and Solid Tumors
Joined July 2013
- Tweets 512
- Following 2,562
- Followers 1,581
- Likes 510
91 Photos and videos
Pinned Tweet
3 May 2023
While this is an amazing achievement, the @gsk vaccines is only focused on preventing #RSV for older adults. @Codagenix is developing an #intranasal #vaccine for #pediatrics
#BREAKING: FDA approves first RSV vaccine, a long-sought scientific achievement trib.al/sCA9UTU #FDA #RSV
2
4
19
7,651
28 Mar 2024
Dr. Jeffrey Fu, CBO, Codagenix, describes what is needed in next-generation COVID vaccines.
Our vaccine program strives address these factors as a live-attenuated, intranasal vaccine that induces an antibody and cell-mediated immunity (CMI).
Learn more: codagenix.com
8
3
19
3,249
21 Mar 2024
Did you know? RSV poses a significant risk to children; more than half of RSV deaths occur in children ages 6 months and older.
Learn more about our work to develop an RSV vaccine for children: codagenix.com
2
1,430
14 Mar 2024
Our live-attenuated #vaccines leverage proven manufacturing methods for widespread access and delivery.
Learn more: codagenix.com/approach/
2
1
10
1,407
7 Mar 2024
At Codagenix, we're combining cutting-edge AI and #syntheticbiology to create safer, more effective live-attenuated #virus #vaccines. ️
Learn more: codagenix.com/approach/
4
1
8
1,187
11 Feb 2024
Today, on International Day of Women and Girls in Science, we shine a spotlight on the incredible #womeninscience who push the boundaries of science and healthcare, including our very own Director of Preclinical Operations, Keri Wyllie, MPA.
Learn more: unesco.org/en/days/women-gir…
5
966
1 Feb 2024
#ICYMI – Check this article from @ritarubin on @JAMA_current highlighting Codagenix's work on next-gen #vaccines, incl. those targeting the mucosal immune system via the nose, mimicking the natural infection route.
Read the full article: jamanetwork.com/journals/jam…
1
2
12
1,653
25 Jan 2024
Curious to learn about the biggest takeaways from #JPM24? Check out this article from @BioSpace that includes updates from Codagenix and many more.
Read here: biospace.com/article/jpm-202…
#biopharma #biotech #innovation #healthcare
2
3
899
23 Jan 2024
Codagenix CEO, Paul Grint, MD, was interviewed for this @WSJVC feature by Brian Gormley about the recent uptick in #biotech acquisitions.
Read here: wsj.com/articles/biotech-acq…
#biopharma #innovation #healthcare
2
4
555
18 Jan 2024
#ICYMI - Codagenix was featured in this article from Jon Cohen (@sciencecohen) of @ScienceMagazine about Project NextGen, a U.S. government initiative investing billions in COVID-19 R&D.
Read the full article: science.org/content/article/…
8
887
16 Jan 2024
Check out this article from @cwillyard in @techreview about the future of needle-free COVID #vaccines, and how Codagenix is among the companies leading the way.
technologyreview.com/2023/12…
2
2
8
698
11 Jan 2024
Thank you @ritarubin and @JAMA_current for highlighting Codagenix's work on next-gen #vaccines, including those targeting the mucosal immune system via the nose, mimicking the natural route of the virus.
Read the full article: jamanetwork.com/journals/jam…
1
6
11
1,439
10 Jan 2024
This #JPM24, Codagenix’s CEO Paul Grint had the opportunity to speak with Tyler Patchen of @BioSpace about Codagenix’s live attenuated virus approach to #vaccine development.
Read the full article: biospace.com/article/jpm-202…
2
2
6
1,069
9 Jan 2024
Team Codagenix is attending the 2024 JPMorgan Healthcare Conference in San Francisco, January 8-11. Contact us to schedule a meeting.
Learn more about our work: codagenix.com
#JPM2024 #JPM24
3
519
7 Dec 2023
Dr. Johanna Kaufmann, EVP Oncology and Immunology, will be participating in a panel at the 8th Annual Oncolytic Virotherapy Summit on December 14 at noon ET. We hope to see you there!
Learn more: ter.li/41bxld
2
440
6 Dec 2023
#DYK that virotherapies have the potential to modulate the tumor microenvironment and trigger immune mechanisms to fight #cancer? At Codagenix, we explore novel #virotherapeutics for #breastcancer and other solid tumors.
Learn more about our pipeline: codagenix.com/pipeline/
3
341
30 Nov 2023
Thank you @BioWorld for highlighting Codagenix’s @DeptofDefense award of $5.88 million to advance its tetravalent #dengue #vaccine program.
Learn more: bioworld.com/articles/702195…
3
377
28 Nov 2023
#ICYMI - Codagenix was featured in this article from Jon Cohen (@sciencecohen) of @ScienceMagazine about Project NextGen, a U.S. government initiative investing billions in COVID-19 R&D.
Read the full article: science.org/content/article/…
2
3
4
552
24 Nov 2023
This Thanksgiving, we are #grateful for the incredible team of scientists and researchers at Codagenix who are dedicated to taking on the biggest threats in #infectiousdiseases and #cancer through our powerful codon-modification platform.
4
398
21 Nov 2023
Dr. Johanna Kaufmann, EVP Oncology and Immunology, recently spoke to @sabrinaserani of @TargetedOnc about Codagenix’s #oncolytic #virotherapy platform.
Watch the full interview: targetedonc.com/view/new-pat…
1
2
515
26 Oct 2023
Today Codagenix announced the presentation of preclinical data for CodaLytic™, a codon-modified virus being developed for #breastcancer #immunovirotherapy, at the @sitcancer 38th Annual Meeting taking place November 1-5, 2023, in San Diego, California.
prnewswire.com/news-releases…
1
3
451